Does Methotrexate Lower Your Immune System?

Methotrexate does lower immune system activity, but not in the way most people picture when they hear “immune suppression.” It is not a broad wipeout of your body’s defenses. At the doses used for rheumatoid arthritis, psoriasis, and similar conditions, it dials down specific parts of the immune response that are driving inflammation. At much higher doses used in cancer treatment, the effect is far broader and more intense.

That distinction matters because “lowering the immune system” can mean anything from a mild dampening of overactive inflammation to a near-total suppression of bone marrow function. Methotrexate sits at different points on that spectrum depending on the dose and the condition being treated.

How Does Methotrexate Affect the Immune System?

Methotrexate works by blocking an enzyme called dihydrofolate reductase, which cells need to make DNA and to divide. That single mechanism explains most of what the drug does, both the benefits and the risks.

Immune cells that are actively dividing and multiplying are hit hardest. In autoimmune conditions, the problem is that certain immune cells are overactive and multiplying when they should not be. Methotrexate interferes with that process. It also increases levels of a molecule called adenosine, which has its own calming effect on inflammation. Both actions together reduce the immune-driven attack on the body’s own tissues.

The result is not a blanket shutdown. Your immune system still fights infections. It still responds to vaccines, though sometimes less strongly. What changes is the intensity of the inflammatory response that was causing joint damage, skin plaques, or other symptoms.

This is why doctors describe methotrexate as a disease-modifying antirheumatic drug, or DMARD. It does not just mask symptoms the way a painkiller might. It changes how the disease behaves over time.

Does Methotrexate Lower Your Immune System at Low Doses?

Yes, even at the low doses used for autoimmune conditions, methotrexate reduces immune system activity. But the reduction is targeted rather than global.

Low-dose methotrexate typically means somewhere in the range of 7.5 to 25 milligrams taken once weekly. That weekly schedule is not arbitrary. It allows the drug to affect dividing immune cells while giving normal tissues time to recover. Daily dosing at these amounts would be far more toxic.

At these doses, the main immune effects are:

• Reduced proliferation of certain white blood cells involved in inflammation
• Lower production of inflammatory signaling molecules
• Mildly increased risk of certain infections, particularly those that require strong T-cell responses

Most people on low-dose methotrexate do not get sick more often in any obvious way. Some do. The risk of serious infection is real but generally modest at these doses, and it goes up when methotrexate is combined with other immunosuppressive drugs or biologics.

Does High-Dose Methotrexate Suppress the Immune System Differently?

High-dose methotrexate, used in cancer treatment, suppresses the immune system far more deeply. Doses can be hundreds or even thousands of milligrams, given intravenously and often followed by a “rescue” drug called leucovorin to protect normal cells.

At these levels, the drug affects rapidly dividing cells throughout the body, not just immune cells. That includes cells in the bone marrow, the lining of the mouth and gut, and hair follicles. This is why cancer patients on high-dose methotrexate may experience low blood cell counts, mouth sores, and hair loss.

The immune suppression at these doses is significant and can last for days to weeks after each treatment cycle. Doctors monitor blood counts closely and time treatments around recovery.

So the answer to “does methotrexate lower your immune system” depends heavily on which methotrexate you mean. The weekly pill for arthritis and the intravenous infusion for cancer are the same drug but not the same treatment.

What Does Immune Suppression From Methotrexate Mean in Daily Life?

For most people on low-dose methotrexate, daily life does not change dramatically. You are not confined to the house or told to avoid all crowds. But there are practical considerations worth understanding.

Infections may hit a little harder or last a little longer. A cold that might have been minor could linger. More importantly, certain infections that a healthy immune system handles easily can become serious. These include infections that require strong T-cell activity, such as tuberculosis, shingles, and some fungal infections.

Doctors often screen for latent tuberculosis and hepatitis before starting methotrexate, precisely because the drug can allow a dormant infection to reactivate.

Vaccines also work differently. Live vaccines, such as the measles-mumps-rubella or varicella vaccines, are generally avoided while on methotrexate because a weakened immune system may not handle even a weakened virus safely. Inactivated vaccines, like the flu shot, are considered safe but may produce a weaker immune response than in someone not taking the drug.

This is not a reason to skip vaccines. It is a reason to talk with your doctor about timing and which vaccines are appropriate.

Does Methotrexate Increase Infection Risk?

Methotrexate does increase infection risk, and the increase is dose-dependent. Higher doses and combination with other immunosuppressive drugs raise the risk more.

Research consistently shows that people taking methotrexate for rheumatoid arthritis have a modestly higher rate of serious infections compared to people not taking it. The absolute increase is not enormous for most people, but it is real and it is why monitoring matters.

Several factors amplify the risk:

• Taking methotrexate alongside biologics like TNF inhibitors
• Taking corticosteroids at the same time
• Being older or having other health conditions
• Having poorly controlled diabetes or kidney disease

The drug is cleared by the kidneys, so kidney function affects how long methotrexate stays in the body and how much it accumulates. This is one reason regular blood tests are part of treatment.

How Do Doctors Monitor Immune Effects of Methotrexate?

Doctors monitor methotrexate through regular blood tests, usually every few months once a stable dose is reached and more often when starting or adjusting the dose. These tests check blood cell counts, liver enzymes, and kidney function.

The blood count matters because methotrexate can suppress bone marrow, which is where immune cells and red blood cells are made. If white blood cell counts drop too low, the risk of infection climbs. If liver enzymes rise, the dose may need adjusting.

Monitoring does not prevent all problems, but it catches many of them early. People on methotrexate are also usually advised to limit alcohol, since both the drug and alcohol stress the liver.

Folic acid supplements are commonly prescribed alongside methotrexate. They do not cancel the drug’s immune effects, but they reduce some side effects like mouth sores and nausea. This is standard practice, though the exact benefit varies between individuals.

Is Methotrexate the Same as “Chemotherapy” for Immune Purposes?

Methotrexate is technically a chemotherapy drug, and it is used in cancer treatment. But the doses and the intent are different when it is used for autoimmune conditions.

In cancer, the goal is to kill rapidly dividing cells, including cancer cells. In autoimmune disease, the goal is to calm an overactive immune response, not to destroy it. The dose for arthritis might be 10 to 20 milligrams per week. The dose for certain cancers can be hundreds of times higher.

Calling low-dose methotrexate “chemotherapy” can be misleading, even though it is accurate in a narrow sense. The experience of taking it for arthritis is not the same as the experience of chemotherapy for cancer. That said, it is still a serious medication that requires monitoring and respect.

Frequently Asked Questions